RxDoctor Payments Data

Calvin Blount, MD

Family Medicine · Miramar Beach, FLNPI 1164404588

Payments from drug & device makers

$1,753in general payments, 2019–2025

Across 80 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$328
  • Novo Nordisk$230
  • Amarin Pharma, Inc.$198
  • AbbVie$149
  • Phathom Pharmaceuticals, Inc.$134
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$124
  • plus $589 from 15 others

What the payments were for

  • Food & beverage$1,753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,753 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$45,729
Medicare patients
131
Services billed
13,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide113$109,627
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$21,156
OzempicSemaglutide14$19,010
EliquisApixaban14$18,981
Tresiba Flextouch U-200Insulin Degludec11$12,678
MyrbetriqMirabegron14$6,171
Breo ElliptaFluticasone/Vilanterol11$4,357
SynthroidLevothyroxine Sodium21$2,801
Aripiprazole12$2,637
Liothyronine Sodium31$1,658
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$1,493
Testosterone Cypionate13$1,431
Estradiol13$1,268
ProgesteroneProgesterone, Micronized35$1,244
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav55$1,212

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$73$109,627113 claims
Novo NordiskOzempic$230$19,01014 claims
PfizerEliquis$105$18,98114 claims
Astellas Pharma US IncMyrbetriq$39$6,17114 claims
AbbVieSynthroid$149$2,80121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Miramar Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →